Cite
Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial.
MLA
Vigneswaran, Hari Thambiah, et al. “Stockholm3 Validation in a Multi-Ethnic Cohort for Prostate Cancer (SEPTA) Detection: A Multicentered, Prospective Trial.” Journal of Clinical Oncology, vol. 42, Feb. 2024, p. 262. EBSCOhost, https://doi.org/10.1200/JCO.2024.42.4_suppl.262.
APA
Vigneswaran, H. T., Eklund, M., Discacciati, A., Nordström, T., Hubbard, R. A., Perlis, N., Abern, M., Moreira, D., Eggener, S. E., Yonover, P. M., Chow, A., Watts, K., Liss, M. A., Thoreson, G. R., Abreu, A. L., Sonn, G. A., Palsdottir, T., Wiklund, F., Gronberg, H., & Murphy, A. B. (2024). Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial. Journal of Clinical Oncology, 42, 262. https://doi.org/10.1200/JCO.2024.42.4_suppl.262
Chicago
Vigneswaran, Hari Thambiah, Martin Eklund, Andrea Discacciati, Tobias Nordström, Rebecca A. Hubbard, Nathan Perlis, Michael Abern, et al. 2024. “Stockholm3 Validation in a Multi-Ethnic Cohort for Prostate Cancer (SEPTA) Detection: A Multicentered, Prospective Trial.” Journal of Clinical Oncology 42 (February): 262. doi:10.1200/JCO.2024.42.4_suppl.262.